E-Learning

Here is how Editas Medicine (EDIT) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.

Here is how Centerra Gold Inc. (CGAU) and New Gold (NGD) have performed compared to their sector so far this year.

Here is how Abacus Life, Inc. (ABL) and Annaly Capital Management (NLY) have performed compared to their sector so far this year.

Here is how Fanuc Corp. (FANUY) and Gorman-Rupp (GRC) have performed compared to their sector so far this year.

Here is how Dunelm Group (DNLMY) and Madison Square Garden Entertainment (MSGE) have performed compared to their sector so far this year.

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Sera Prognostics (SERA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

The average brokerage recommendation (ABR) for Cava (CAVA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Based on the average brokerage recommendation (ABR), Cipher Mining (CIFR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?